VION Biosciences Acquires Echelon Biosciences, Specialist in Lipids and Nanoparticles

VION Biosciences, a company specializing in life science reagents, has acquired Echelon Biosciences, a key supplier of lipid-based materials. This acquisition is the second under VION Biosciences LLC, the roll-up platform from Iron Path Capital led by Mark Thornton. Echelon,…

Read MoreVION Biosciences Acquires Echelon Biosciences, Specialist in Lipids and Nanoparticles

TFI Grants Third Biostimulant Certification to Valent BioSciences for Transit® 500

We are excited to announce that Valent BioSciences’ Transit 500 biostimulant has been recognized as a Certified Biostimulant by TFI,” said TFI President and CEO Corey Rosenbusch. “Biostimulant products have been shown to promote nutrient uptake, stress tolerance, and overall…

Read MoreTFI Grants Third Biostimulant Certification to Valent BioSciences for Transit® 500

Chemify Names Kevin McGowan Chief Business Officer to Boost Digital Chemistry Growth

Chemify, a deep-tech company that integrates chemistry, robotics, and AI to digitally design, discover, and synthesize new molecules, has announced the appointment of Kevin McGowan, PhD, MBA, as Chief Business Officer (CBO). McGowan, an expert in pharmaceutical business development, platform…

Read MoreChemify Names Kevin McGowan Chief Business Officer to Boost Digital Chemistry Growth

Bio-Gene and Envu Partner to Assess Flavocide™ for Mosquito Control in Public and Private Sectors

Bio-Gene Technology Limited, an Australian company focused on the development of next-generation bio-insecticides, is collaborating with Envu to evaluate Flavocide™ for use in professional pest control and public health products aimed at mosquito management. Envu, a global leader in environmental…

Read MoreBio-Gene and Envu Partner to Assess Flavocide™ for Mosquito Control in Public and Private Sectors